UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
|
|
|
|
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 28, 2005
|
ANGIODYNAMICS, INC. |
|
|
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
|
|
(State or Other Jurisdiction of Incorporation)
|
0-50761 |
|
11-3146460 |
|
|
|
|
|
|
(Commission File Number) |
(IRS Employer Identification No.) |
|
603 Queensbury Avenue, Queensbury, New York |
|
12804 |
|
|
|
|
|
|
(Address of Principal Executive Offices) |
(Zip Code) |
|
(518) 798-1215 |
|
|
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Item 5.02. |
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
(b) On December 28, 2005, AngioDynamics, Inc. (the “Company”) learned of the death that same day of Howard S. Stern, a director and co-founder of the Company. On January 3, 2006, the Company issued a press release announcing Mr. Stern’s death. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference in its entirety.
|
Item 9.01. |
Financial Statements and Exhibits |
|
|
(d) |
Exhibits |
|
|
Press Release issued by AngioDynamics, Inc. on January 3, 2006. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: January 4, 2006 |
ANGIODYNAMICS, INC. |
(Registrant)
By:/s/ Joseph G. Gerardi
Joseph G. Gerardi
Vice President, Chief Financial Officer
3
EXHIBIT INDEX
|
Exhibit |
Description |
|
|
99.1 |
Press Release issued by AngioDynamics, Inc. on January 3, 2006. |
4